Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis
- 4 May 2020
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 100 (9) , 1184-1196
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47Matrix Biology, 2012
- Plasma thrombospondin‐1 is increased during acute sickle cell vaso‐occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic ratesAmerican Journal of Hematology, 2011
- New Insights into Epithelial-Mesenchymal Transition in Kidney FibrosisJournal of the American Society of Nephrology, 2010
- Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney FibrosisThe American Journal of Pathology, 2010
- Thrombospondin-1/CD47 Blockade following Ischemia-Reperfusion Injury Is Tissue ProtectivePlastic and Reconstructive Surgery, 2009
- Thrombospondin-1–CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO–cGMP pathway activationNitric Oxide, 2009
- Correlation of enhanced thrombospondin-1 expression, TGF- signalling and proteinuria in human type-2 diabetic nephropathyNephrology Dialysis Transplantation, 2008
- Blockade of Thrombospondin-1-CD47 Interactions Prevents Necrosis of Full Thickness Skin GraftsAnnals of Surgery, 2008
- Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxationBlood, 2006